Postal Ballot: Issue of 10 lakh warrants to promoter at Rs 81 each
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bal Pharma is seeking shareholder approval via postal ballot to issue 10,00,000 convertible warrants to promoter Mr. Shailesh Siroya at Rs 81 each, aggregating about Rs 8.10 crore. Warrants carry a Rs 71 premium over the Rs 10 face value, with 25 percent payable upfront and the rest on conversion into equal equity shares within 18 months. Proceeds will part fund a greenfield API manufacturing facility at Yadagiri, Karnataka, where land has been acquired and environmental clearance obtained. Promoter Mr. Siroya stake rises from about 17.24 percent to 22.13 percent assuming full conversion. E-voting runs from July 10 to August 8, 2026.
Signals promoter confidence and funds API expansion; non-promoter holders face mild dilution as promoter stake rises.